These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 16455785)
1. Hepatic cytochrome P-450 reductase-null mice show reduced transcriptional response to quercetin and reveal physiological homeostasis between jejunum and liver. Mutch DM; Crespy V; Clough J; Henderson CJ; Lariani S; Mansourian R; Moulin J; Wolf CR; Williamson G Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G63-72. PubMed ID: 16455785 [TBL] [Abstract][Full Text] [Related]
2. The disruption of hepatic cytochrome p450 reductase alters mouse lipid metabolism. Mutch DM; Klocke B; Morrison P; Murray CA; Henderson CJ; Seifert M; Williamson G J Proteome Res; 2007 Oct; 6(10):3976-84. PubMed ID: 17722906 [TBL] [Abstract][Full Text] [Related]
3. The hepatic cytochrome P450 reductase null mouse as a tool to identify a successful candidate entity. Henderson CJ; Pass GJ; Wolf CR Toxicol Lett; 2006 Mar; 162(1):111-7. PubMed ID: 16343823 [TBL] [Abstract][Full Text] [Related]
4. Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse. Stiborová M; Arlt VM; Henderson CJ; Wolf CR; Kotrbová V; Moserová M; Hudecek J; Phillips DH; Frei E Toxicol Appl Pharmacol; 2008 Feb; 226(3):318-27. PubMed ID: 17976674 [TBL] [Abstract][Full Text] [Related]
5. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse. Pass GJ; Carrie D; Boylan M; Lorimore S; Wright E; Houston B; Henderson CJ; Wolf CR Cancer Res; 2005 May; 65(10):4211-7. PubMed ID: 15899812 [TBL] [Abstract][Full Text] [Related]
6. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice. Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863 [TBL] [Abstract][Full Text] [Related]
7. Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity. Xue X; Gong L; Qi X; Wu Y; Xing G; Yao J; Luan Y; Xiao Y; Li Y; Wu X; Chen M; Gu J; Ren J Toxicol Lett; 2011 Aug; 205(1):47-54. PubMed ID: 21596114 [TBL] [Abstract][Full Text] [Related]
8. Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection. Savov VM; Galabov AS; Tantcheva LP; Mileva MM; Pavlova EL; Stoeva ES; Braykova AA Exp Toxicol Pathol; 2006 Aug; 58(1):59-64. PubMed ID: 16793246 [TBL] [Abstract][Full Text] [Related]
9. Modification of the metabolism and toxicity of styrene and styrene oxide in hepatic cytochrome P450 reductase deficient mice and CYP2F2 deficient mice. Carlson GP Toxicology; 2012 Apr; 294(2-3):104-8. PubMed ID: 22386858 [TBL] [Abstract][Full Text] [Related]
10. Rescue of cytochrome P450 oxidoreductase (Por) mouse mutants reveals functions in vasculogenesis, brain and limb patterning linked to retinoic acid homeostasis. Ribes V; Otto DM; Dickmann L; Schmidt K; Schuhbaur B; Henderson C; Blomhoff R; Wolf CR; Tickle C; Dollé P Dev Biol; 2007 Mar; 303(1):66-81. PubMed ID: 17126317 [TBL] [Abstract][Full Text] [Related]
11. Role of small intestinal cytochromes p450 in the bioavailability of oral nifedipine. Zhang QY; Kaminsky LS; Dunbar D; Zhang J; Ding X Drug Metab Dispos; 2007 Sep; 35(9):1617-23. PubMed ID: 17567730 [TBL] [Abstract][Full Text] [Related]
12. RNA-interference approach to study functions of NADPH : cytochrome P450 oxidoreductase in human hepatocytes. Feidt DM; Klein K; Nüssler A; Zanger UM Chem Biodivers; 2009 Nov; 6(11):2084-91. PubMed ID: 19937842 [TBL] [Abstract][Full Text] [Related]